IOP Medical
Implantable Sensor for Self-monitoring of Intraocular Pressure
Company Overview
Snapshot
Founded in June 2016 by Prof. Yossi Mandel, IOP Medical operates with 1–10 employees. The company has secured funding from 2 investors across one funding round, with G.O Innovation and Stanford University participating. IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure, leveraging technology patented at Stanford University.
Business overview
IOP Medical is an ophthalmology startup focused on developing an implantable sensor for self-monitoring of intraocular pressure. The core technology, developed and patented at Stanford University, enables users to monitor their intraocular pressure using a simple smartphone camera. The company operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and medical devices for chronic patients, particularly those with glaucoma, and serves global markets.
Log in to access full profile ›Company Intelligence Q&A
- What is IOP Medical's core technology?
- IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure, utilizing technology patented at Stanford University. This device allows users to monitor their condition with a smartphone camera.
- Who founded IOP Medical and when?
- IOP Medical was founded in June 2016 by Prof. Yossi Mandel, who also serves as the Chief Scientist and Inventor.
- Which investors participated in IOP Medical's funding round?
- In January 2019, IOP Medical received funding from G.O Innovation and Stanford University.
- What markets does IOP Medical target?
- IOP Medical targets the global market, focusing on digital healthcare and medical devices for chronic patients, particularly those with glaucoma, through remote monitoring solutions.
- What is the current product stage of IOP Medical?
- IOP Medical's product is currently in the R&D stage, focusing on the development of its implantable sensor technology.